Cargando…

Autoimmune Hepatitis Triggered by COVID-19 Vaccine: The First Case From Inactivated Vaccine

We report a case of a 52-year-old woman without previous underlying liver disease, presenting with progressive jaundice and diagnosed with autoimmune hepatitis after 2 doses of an inactivated coronavirus disease 2019 (CoronaVac) vaccine. All serology and histology were compatible with autoimmune hep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mekritthikrai, Krittaya, Jaru-Ampornpan, Peera, Komolmit, Piyawat, Thanapirom, Kessarin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246078/ https://www.ncbi.nlm.nih.gov/pubmed/35784513 http://dx.doi.org/10.14309/crj.0000000000000811

Ejemplares similares

Eliminating viral hepatitis in children after liver transplants: How to reach the goal by 2030
por: Sintusek, Palittiya, et al.
Publicado: (2022)

Assessment and validation of the TREAT-B score to assess the treatment eligibility of patients with chronic hepatitis B virus infection
por: Thanapirom, Kessarin, et al.
Publicado: (2022)

Psychometric Hepatic Encephalopathy Score for the Diagnosis of Minimal Hepatic Encephalopathy in Thai Cirrhotic Patients
por: Thanapirom, Kessarin, et al.
Publicado: (2023)

Hepatic Necrosis Mimicking Infiltrative Masses in Acute Budd-Chiari Syndrome With Hereditary Protein C Deficiency
por: Ananchuensook, Prooksa, et al.
Publicado: (2022)

Immunogenicity and Safety of the Third Booster Dose with mRNA-1273 COVID-19 Vaccine after Receiving Two Doses of Inactivated or Viral Vector COVID-19 Vaccine
por: Tangsathapornpong, Auchara, et al.
Publicado: (2023)

Correction of vitamin D deficiency facilitated suppression of IP-10 and DPP IV levels in patients with chronic hepatitis C: A randomised double-blinded, placebo-control trial
por: Komolmit, Piyawat, et al.
Publicado: (2017)

Vitamin D supplementation improves serum markers associated with hepatic fibrogenesis in chronic hepatitis C patients: A randomized, double-blind, placebo-controlled study
por: Komolmit, Piyawat, et al.
Publicado: (2017)

The association between vitamin D receptor polymorphism and phases of chronic hepatitis B infection in HBV carriers in Thailand
por: Ananchuensook, Prooksa, et al.
Publicado: (2022)

Hepatopleural Fistula with Empyema Thoracis: A Rare Complication of Autosomal Dominant Polycystic Kidney Disease
por: Maytapa, Jeerawat, et al.
Publicado: (2018)

Genetic associations of vitamin D receptor polymorphisms with advanced liver fibrosis and response to pegylated interferon-based therapy in chronic hepatitis C
por: Thanapirom, Kessarin, et al.
Publicado: (2019)

Immunogenicity of an mRNA-Based COVID-19 Vaccine among Adolescents with Obesity or Liver Transplants
por: Tubjaroen, Chomchanat, et al.
Publicado: (2022)

Stability of hepatitis B virus pregenomic RNA in plasma specimens under various temperatures and storage conditions
por: Rattanachaisit, Pakkapon, et al.
Publicado: (2021)

Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients
por: Thanapirom, Kessarin, et al.
Publicado: (2017)

Clinical significance of post-liver transplant hepatitis E seropositivity in high prevalence area of hepatitis E genotype 3: a prospective study
por: Komolmit, Piyawat, et al.
Publicado: (2020)

Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis
por: Navadurong, Huttakan, et al.
Publicado: (2023)

Association between CXCL10 and DPP4 Gene Polymorphisms and a Complementary Role for Unfavorable IL28B Genotype in Prediction of Treatment Response in Thai Patients with Chronic Hepatitis C Virus Infection
por: Thanapirom, Kessarin, et al.
Publicado: (2015)

Immunogenicity, Immune Dynamics, and Subsequent Response to the Booster Dose of Heterologous versus Homologous Prime-Boost Regimens with Adenoviral Vector and mRNA SARS-CoV-2 Vaccine among Liver Transplant Recipients: A Prospective Study
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2022)

Tu1269: IMMUNOGENICITY AND SAFETY OF HETEROLOGOUS VERSUS HOMOLOGOUS PRIME-BOOST REGIMENS WITH ADENOVIRAL VECTORED AND MRNA SARS-COV-2 VACCINE IN LIVER TRANSPLANT RECIPIENTS
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2022)

Immunogenicity and safety of heterologous versus homologous prime-boost regimens with adenoviral vectored and mRNA SARS-CoV-2 vaccine in liver transplant recipients: a prospective study
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2022)

Durability of SARS-CoV-2 specific immune response following different primary prime-boost vaccine platforms and subsequent humoral response to booster dose among liver transplant recipients
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2022)

The incidence, etiologies, outcomes, and predictors of mortality of acute liver failure in Thailand: a population-base study
por: Thanapirom, Kessarin, et al.
Publicado: (2019)

Heterologous Prime-boost of SARS-CoV-2 inactivated vaccine and mRNA BNT162b2 among Healthy Thai Adolescents
por: Puthanakit, Thanyawee, et al.
Publicado: (2022)

Nucleocapsid proteins from other swine enteric coronaviruses differentially modulate PEDV replication
por: Sungsuwan, Suttipun, et al.
Publicado: (2020)

Non-invasive tests for liver fibrosis assessment in patients with chronic liver diseases: a prospective study
por: Thanapirom, Kessarin, et al.
Publicado: (2022)

Changes in hepatic fibrosis and vitamin D levels after viral hepatitis C eradication using direct-acting antiviral therapy
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2020)

COVID-19 vaccination triggered autoimmune hepatitis
por: Shinde, Kiran D., et al.
Publicado: (2022)

Immunogenicity to SARS-CoV-2 Omicron variant among school-aged children with 2-dose of inactivated SARS-CoV-2 vaccines followed by BNT162b2 booster
por: Chantasrisawad, Napaporn, et al.
Publicado: (2022)

Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization
por: Ananchuensook, Prooksa, et al.
Publicado: (2022)

A randomized clinical trial of a booster dose with low versus standard dose of AZD1222 in adult after 2 doses of inactivated vaccines
por: Nanthapisal, Sira, et al.
Publicado: (2022)

Screening for non‐alcoholic fatty liver disease in community setting: A cohort study using controlled attenuation parameter‐transient elastography
por: Teeratorn, Nicha, et al.
Publicado: (2019)

Autoimmune hepatitis triggered by COVID-19 vaccination: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Modified albumin-bilirubin predicted survival of unresectable hepatocellular carcinoma patients treated with immunotherapy
por: Navadurong, Huttakan, et al.
Publicado: (2023)

Growth enhancement of porcine epidemic diarrhea virus (PEDV) in Vero E6 cells expressing PEDV nucleocapsid protein
por: Liwnaree, Benjamas, et al.
Publicado: (2019)

Zinc-finger antiviral protein-mediated inhibition of porcine epidemic diarrhea virus growth is antagonized by the coronaviral nucleocapsid protein
por: Sungsuwan, Suttipun, et al.
Publicado: (2022)

Effect of vitamin D supplementation in patients with chronic hepatitis C after direct-acting antiviral treatment: a randomized, double-blind, placebo-controlled trial
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2021)

PEDV ORF3 Independently Regulates IκB Kinase β-Mediated NF-κB and IFN-β Promoter Activities
por: Kaewborisuth, Challika, et al.
Publicado: (2020)

Evaluation of Methylotrophic Yeast Ogataea thermomethanolica TBRC 656 as a Heterologous Host for Production of an Animal Vaccine Candidate
por: Liwnaree, Benjamas, et al.
Publicado: (2022)

The mRNA COVID-19 vaccine – A rare trigger of autoimmune hepatitis?
por: McShane, Cathy, et al.
Publicado: (2021)

Polymyositis Associated with Hepatitis B Virus Cirrhosis and Advanced Hepatocellular Carcinoma
por: Thanapirom, Kessarin, et al.
Publicado: (2014)

A fully covered self-expandable metallic stent as a cystic-duct overtube facilitated stone removal from a gallbladder
por: Ridtitid, Wiriyaporn, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kan7ns68igtoqblfpb00ugjdor